• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

某些强心剂对哺乳动物心脏脱细胞纤维收缩性的影响。

Effects of some cardiotonic agents on contractility of skinned fibers from mammalian heart.

作者信息

van Meel J C

机构信息

Department of Cardiovascular Research, Dr. Karl Thomae GmbH, Biberach an der Riss, Fed. Rep. of Germany.

出版信息

Arzneimittelforschung. 1987 Jun;37(6):679-82.

PMID:3663265
Abstract

Nine cardiotonics of different chemical structure were investigated on their ability to influence calcium-induced isometric contractions of chemically skinned porcine myocardial fibers. It was found that at a concentration of 10(-4) mol/l amrinone, enoximone, imazodan, milrinone, piperanometozine and piroximone were without effect on calcium-induced tension development of skinned fibers. 3-Amino-6-methyl-5-phenyl-2(1H)-pyridinone (APP), pimobendan and sulmazole enhanced the isometric contractions induced by 0.66 mumol/l Ca++ concentration-dependently. The intrinsic activity of pimobendan was much higher than for sulmazole or APP. Comparing equieffective concentrations inducing 35% additional tension development, the rank order of potency was: pimobendan greater than APP greater than sulmazole.

摘要

研究了九种不同化学结构的强心剂对化学去表皮猪心肌纤维钙诱导等长收缩的影响能力。结果发现,在浓度为10(-4)mol/l时,氨力农、依诺昔酮、咪唑旦、米力农、哌拉诺美嗪和吡罗昔酮对去表皮纤维的钙诱导张力发展没有影响。3-氨基-6-甲基-5-苯基-2(1H)-吡啶酮(APP)、匹莫苯丹和舒马唑以浓度依赖的方式增强了由0.66μmol/l Ca++诱导的等长收缩。匹莫苯丹的内在活性远高于舒马唑或APP。比较诱导额外35%张力发展的等效浓度,效价顺序为:匹莫苯丹>APP>舒马唑。

相似文献

1
Effects of some cardiotonic agents on contractility of skinned fibers from mammalian heart.某些强心剂对哺乳动物心脏脱细胞纤维收缩性的影响。
Arzneimittelforschung. 1987 Jun;37(6):679-82.
2
Increase in Ca++ sensitivity of the contractile system by MCI-154, a novel cardiotonic agent, in chemically skinned fibers from the guinea pig papillary muscles.新型强心剂MCI - 154对豚鼠乳头肌化学去膜纤维收缩系统Ca++敏感性的增强作用。
J Pharmacol Exp Ther. 1987 Nov;243(2):633-8.
3
Effect of sulmazole and pimobendan on contractility of skinned fibres from frog skeletal muscle.舒马唑和匹莫苯丹对青蛙骨骼肌脱细胞纤维收缩性的影响。
Arzneimittelforschung. 1987 Oct;37(10):1141-3.
4
Xestoquinone, a novel cardiotonic agent activates actomyosin ATPase to enhance contractility of skinned cardiac or skeletal muscle fibers.司托醌,一种新型强心剂,可激活肌动球蛋白ATP酶,以增强皮肤化心肌或骨骼肌纤维的收缩力。
J Pharmacol Exp Ther. 1991 Apr;257(1):90-4.
5
Comparison of the effects of MCI-154, a new cardiotonic agent, and some Ca2+-sensitizing agents on the response of the contractile system to Ca2+ in skinned cardiac muscle.新型强心剂MCI - 154与某些钙敏化剂对去表皮心肌收缩系统对钙离子反应影响的比较
Jpn J Pharmacol. 1989 Aug;50(4):411-9. doi: 10.1254/jjp.50.411.
6
MCI-154, a novel cardiotonic agent, reverses the acidic pH-induced decrease in responses of cardiac myofilaments to Ca++: comparison with sulmazole and pimobendan.新型强心剂MCI - 154可逆转酸性pH值引起的心肌肌丝对钙离子反应性的降低:与舒马唑和匹莫苯丹的比较。
J Pharmacol Exp Ther. 1991 May;257(2):812-9.
7
Effects of new inotropic agents on Ca++ sensitivity of contractile proteins.新型正性肌力药物对收缩蛋白钙敏感性的影响。
Circulation. 1986 Mar;73(3 Pt 2):III78-84.
8
Sulmazole effects on mechanical performance of hypoxic and reoxygenated isolated mammalian myocardium.舒马唑对缺氧和复氧的离体哺乳动物心肌力学性能的影响。
Arzneimittelforschung. 1986 Nov;36(11):1572-7.
9
The response of the calcium dependent myocardial contractility to the new cardiotonic agent sulmazole.
Arzneimittelforschung. 1984;34(11):1498-506.
10
Effect on contractility of skinned fibres from mammalian heart and smooth muscle by a new benzimidazole derivative, 4,5-dihydro-6-[2-(4-methoxyphenyl)-1H-benzimidazol-5-yl]-5-methy l-3(2H )- pyridazinone.一种新型苯并咪唑衍生物4,5-二氢-6-[2-(4-甲氧基苯基)-1H-苯并咪唑-5-基]-5-甲基-3(2H)-哒嗪酮对哺乳动物心脏和平滑肌去表皮纤维收缩性的影响
Arzneimittelforschung. 1984;34(12):1736-8.

引用本文的文献

1
Pimobendan. A review of its pharmacology and therapeutic potential in congestive heart failure.匹莫苯丹。其在充血性心力衰竭中的药理学及治疗潜力综述。
Drugs Aging. 1994 May;4(5):417-41. doi: 10.2165/00002512-199404050-00007.
2
Recruitment of inotropic reserve in "stunned" myocardium by the cardiotonic agent AR-L 57.强心剂AR-L 57对“顿抑”心肌收缩储备的募集作用
Basic Res Cardiol. 1988 Nov-Dec;83(6):602-10. doi: 10.1007/BF01906954.
3
Relation of positive inotropic and chronotropic effects of pimobendan, UD-CG 212 Cl, milrinone and other phosphodiesterase inhibitors to phosphodiesterase III inhibition in guinea-pig heart.
匹莫苯丹、UD-CG 212 Cl、米力农及其他磷酸二酯酶抑制剂对豚鼠心脏正性肌力和变时作用与磷酸二酯酶III抑制的关系。
Naunyn Schmiedebergs Arch Pharmacol. 1989 May;339(5):575-83. doi: 10.1007/BF00167264.
4
The 'calcium sensitising' effects of ORG30029 in saponin- or Triton-skinned rat cardiac muscle.ORG30029对皂角苷或曲拉通处理的大鼠心肌的“钙致敏”作用。
Br J Pharmacol. 1990 Aug;100(4):843-9. doi: 10.1111/j.1476-5381.1990.tb14102.x.
5
Calcium sensitisers.钙增敏剂
BMJ. 1990 Mar 3;300(6724):551-2. doi: 10.1136/bmj.300.6724.551.